- Report
- June 2026
- 191 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 389 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 376 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 588 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 282 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 196 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 474 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2026
- 732 Pages
Global
From €5200EUR$5,850USD£4,501GBP
- Report
- June 2025
- 400 Pages
Global
From €4399EUR$4,949USD£3,808GBP
- Report
- July 2025
- 350 Pages
Global
From €4399EUR$4,949USD£3,808GBP
- Report
- July 2025
- 350 Pages
Global
From €4399EUR$4,949USD£3,808GBP
- Report
- August 2025
- 149 Pages
Global
From €3511EUR$3,950USD£3,039GBP
- Report
- November 2025
- 160 Pages
Global
From €3511EUR$3,950USD£3,039GBP
- Report
- November 2025
- 160 Pages
Global
From €3511EUR$3,950USD£3,039GBP
- Report
- November 2025
- 160 Pages
Global
From €3511EUR$3,950USD£3,039GBP
- Report
- October 2025
- 160 Pages
Global
From €3511EUR$3,950USD£3,039GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,218USD£3,136GBP
- Report
- July 2025
- 132 Pages
Global
From €4311EUR$4,850USD£3,732GBP
- Report
- January 2026
Global
From €6667EUR$7,500USD£5,771GBP
- Report
- October 2025
- 90 Pages
Global
From €4311EUR$4,850USD£3,732GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more